Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes

被引:174
作者
Ahn, Nayeon [1 ,2 ]
Baumeister, Sebastian E. [1 ]
Amann, Ute [1 ]
Rathmann, Wolfgang [3 ]
Peters, Annette [4 ]
Huth, Cornelia [4 ]
Thorand, Barbara [4 ]
Meisinger, Christa [1 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, UNIKA T Augsburg, Chair Epidemiol, Augsburg, Germany
[2] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany
[3] Heinrich Heine Univ, German Diabet Ctr, Inst Biometr & Epidemiol, Leibniz Ctr Diabet Res, Dusseldorf, Germany
[4] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany
[5] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Independent Res Grp Clin Epidemiol, Neuherberg, Germany
关键词
INSULIN-RESISTANCE; FASTING GLUCOSE; MELLITUS; ASSOCIATION; PREVENTION; PREDICTION; OBESITY; WOMEN; HOMA;
D O I
10.1038/s41598-019-46187-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The present study evaluated the ability of the visceral adiposity index (VAI), the lipid accumulation product (LAP), and product of triglycerides and glucose (TyG), three novel, insulin resistance-related markers, to discriminate prediabetes/diabetes in the general German population. Altogether 2,045 Germans (31-72 years, 53.3% women) without known diabetes and a history of Myocardial Infarction (MI)/stroke from the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study were eligible. The discriminatory accuracy of the markers for oral glucose tolerance test (OGTT)-defined prediabetes/diabetes according to the American Diabetes Association (ADA) criteria was assessed by the area under the receiver operating characteristic (ROC) curve (AUC). The Youden Index (YI) was used to determine optimal cut-off values, and a non-parametric ROC regression was used to examine whether the discriminatory accuracy varied by sex and age. 365 men (38.2%) and 257 women (23.6%) were newly diagnosed with prediabetes/diabetes. AUCs for TyG, LAP and VAI were 0.762 (95%CI 0.740-0.784), 0.743 (95% CI 0.720-0.765), and 0.687 (95%CI 0.662-0.712), respectively. The optimal cut-off values for the LAP and TyG were 56.70 and 8.75 in men, and 30.40 and 8.53 in women. In conclusion, TyG and LAP provide good discrimination of persons with prediabetes/diabetes.
引用
收藏
页数:11
相关论文
共 44 条
[1]   Distribution-free ROC analysis using binary regression techniques [J].
Alonzo, TA ;
Pepe, MS .
BIOSTATISTICS, 2002, 3 (03) :421-432
[2]   Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk [J].
Amato, Marco C. ;
Giordano, Carla ;
Galia, Massimo ;
Criscimanna, Angela ;
Vitabile, Salvatore ;
Midiri, Massimo ;
Galluzzo, Aldo .
DIABETES CARE, 2010, 33 (04) :920-922
[3]   Classification and Diagnosis of Diabetes [J].
不详 .
DIABETES CARE, 2015, 38 :S8-S16
[4]   Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women [J].
Araneta, MRG ;
Barrett-Connor, E .
OBESITY RESEARCH, 2005, 13 (08) :1458-1465
[5]   IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 [J].
Cho, N. H. ;
Shaw, J. E. ;
Karuranga, S. ;
Huang, Y. ;
Fernandes, J. D. da Rocha ;
Ohlrogge, A. W. ;
Malanda, B. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 138 :271-281
[6]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]   Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance [J].
Du, Tingting ;
Yuan, Gang ;
Zhang, Muxun ;
Zhou, Xinrong ;
Sun, Xingxing ;
Yu, Xuefeng .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[8]   PREVENTION OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS BY DIET AND PHYSICAL EXERCISE - THE 6-YEAR MALMO FEASIBILITY STUDY [J].
ERIKSSON, KF ;
LINDGARDE, F .
DIABETOLOGIA, 1991, 34 (12) :891-898
[9]  
Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83
[10]  
Harris MI, 2000, DIABETES-METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO